What are the Challenges in Managing Hypercoagulability in Cancer Patients?
Managing hypercoagulability in cancer patients is challenging due to the delicate balance between preventing clots and avoiding excessive bleeding. Cancer patients often have multiple comorbidities and may be undergoing treatments that further complicate anticoagulation therapy.